The British Business Bank has committed £180m to six venture capital and growth equity funds focused on artificial intelligence and deep technology, expanding the capital available to specialist investors backing technology companies at different stages of development.
The six funds have collectively raised more than £1bn, although that figure represents their total fundraising rather than the Bank’s direct contribution. The commitments are intended to support investment from early-stage technology development through to later-stage expansion.
The largest allocation is £55m to Intrepid Growth Partners Fund I, which is focused on growth-stage AI businesses. The Bank is also committing £35m to Crane III, an investor in foundational technology businesses working across software, infrastructure, artificial intelligence and deep science.
Other commitments include £26m to Headline EU VIII, £22m to Entrepreneurs First’s Early Stage Fund, £22m to Evantic Fund I and £20m to Connect V.
Each vehicle has a different investment mandate. Crane III supports founders from company formation through early funding stages, while Connect V focuses on technical entrepreneurs working at the intersection of AI, hardware and automation. Entrepreneurs First’s fund backs businesses emerging from its founder programme, including companies developing AI infrastructure.
Intrepid provides growth capital for AI-focused companies, while Headline EU VIII will invest in seed and Series A businesses across Europe. Evantic invests in technology companies pursuing larger-scale growth opportunities.
The announcement concerns commitments to investment funds, not direct investments of £180m in six operating companies. Individual portfolio investments will be made by fund managers in accordance with their respective investment strategies and may take place over several years.
The Bank says the investment forms part of its strategy to develop the financing environment for digital technology businesses identified as priorities within the Government’s industrial strategy.
Access to appropriate forms of capital is an important constraint for companies developing technically complex products. Businesses may need to fund research, engineering, specialist recruitment and initial commercial activity before they generate stable revenues, making conventional debt financing less suitable than patient equity capital at some development stages.
Later-stage companies face different requirements. Expanding internationally, increasing manufacturing or infrastructure capacity and entering new markets can demand substantial further investment, even where a technology has already been demonstrated and early customers have been secured.
By investing through specialist funds, the British Business Bank aims to increase the resources available across these different stages. The ultimate allocation to individual UK businesses will depend on managers’ investment decisions, particularly where their mandates extend to companies elsewhere in Europe or internationally.
The commitment follows the Bank’s separate announcement on 14 October of a £10m investment in Salience Labs, an Oxford spinout developing optical switching technology for AI data centres. That transaction involved a direct company investment and is distinct from the six fund commitments announced on 15 October.
The Bank also operates VentureLink, a platform intended to help pension funds and other institutional investors identify venture funds seeking additional limited-partner investment. It reports that 18 funds are currently available through the initiative.
These measures address different components of the venture capital market: the availability of specialist funds, their capacity to finance companies and their ability to attract further institutional capital.
The measurable outcome from the latest announcement will emerge as the six managers deploy funds into portfolio businesses. For the British Business Bank, the commitment establishes a financing channel intended to help technology companies develop and expand, rather than an immediate record of jobs created, products commercialised or investment received by specific firms.
You must be logged in to post a comment.